Bussiness Data like Email, Phone Number, Address, Decision Makers, Location of NanoString Technologies, Inc.

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.

NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter® Analysis System, which has been employed in basic and translational research since it was first introduced in 2008 and cited in more than 300 peer-reviewed publications, has also now been applied to diagnostic use as the nCounter Dx Analysis System. The company's technology offers a cost-effective way to easily profile the expression of hundreds of genes, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. The company's technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The nCounter-based Prosigna™ Breast Cancer Prognostic Gene Signature Assay is the first in vitro diagnostic assay to be marketed through the company's diagnostics business. The nCounter Dx Analysis System is FDA 510(k) cleared for use with the Prosigna Breast Cancer Prognostic Gene Signature Assay. To date, it has not been cleared by the FDA for other indications or for use with other assays.

Leading researchers are finding that NanoString's nCounter system provides the ideal platform on which to validate their discoveries and translate them into clinically useful diagnostic assays. The nCounter system is uniquely positioned to support translational research because it provides more reproducible results than methods requiring amplification, and generates high-quality data from the difficult sample types common in clinical research, including Formalin-Fixed Paraffin-Embedded (FFPE) tissues.

NanoString Technologies, Inc. Overview

Emails of NanoString Technologies, Inc. Employees



To see more emails of NanoString Technologies, Inc. employees and NanoString Technologies, Inc. email patterns, please signup at AeroLeads for free.

NanoString Technologies, Inc. Phone Numbers



To find more company and direct phone numbers of NanoString Technologies, Inc., please signup at AeroLeads for free.

Revenue
-

Employees
501-1,000 employees

CEO
-

CTO

CFO
-

COO
-

CMO

More Data of NanoString Technologies, Inc.


NanoString Technologies, Inc. at Alexa
Description:
Manufacturer of gene expression analysis assays and software, including nCounter analysis system used in biology translational research and molecular diagnostics. Provides technical product support information, company news, events, and contacts.
Keywords:
Categories:
Gene Expression/Products and Services

NanoString Technologies, Inc. website users By Country

Country Users
United States of America 74.7%
Country Users
O 25.5%

Some of NanoString Technologies, Inc. Employees

Dppm10

Duane Kembel

Director
Dppm8

Michael LeDee

Sr Director, QA
Dppm6

Beth Husted

Quality Assurance Manager
Dppm12

Claire McDonnell

Owner and Director
Dppm12

Everton Robinson

Director of EMEA Sales - Life Sciences and Diagnostics
Dppm8

Mark Daniel

Vice President Finance
Dppm4

Elmar Orujov

Associate Director Medical Affairs - Global Medical Communications, Publications
Dppm1

Allison Songstad

Stem Cell Biologist | Field Applications Scientist
Dppm0

Agnese Winfield

Director, Market Development EMEA

Connect